Background Extracorporeal shock wave therapy (ESWT) is a conservative therapy for patients with Peyronie’s disease (PD)…

This placebo-controlled study over 5 weeks shows that 57% of the men who suffered from erectile dysfunction had an effect from low-intensity extracorporeal shockwave therapy (LI-ESWT) . After 24 weeks, seven (19%, active group) and nine (23%, active placebo group) men were still able to have intercourse without medication.  

Low‐energy shockwave therapy (LESWT) has been shown to improve erectile function in patients suffering from diabetes mellitus (DM)‐associated erectile dysfunction (ED).